Induction of immune tolerance in NMOSD and MOGAD
Neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are autoimmune diseases characterized by immune-mediated damage to the central nervous system. Current treatments primarily focus on chronic immunosuppression. Immune tolerance...
Saved in:
| Main Authors: | Jorge Correale, Edgar Carnero Contentti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-07-01
|
| Series: | Therapeutic Advances in Neurological Disorders |
| Online Access: | https://doi.org/10.1177/17562864251357393 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application and interpretation of core elements of the 2015 NMOSD diagnostic criteria in routine clinical practice
by: Edgar Carnero Contentti, et al.
Published: (2024-12-01) -
AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?
by: Diego Cardoso Fragoso, et al.
Published: (2023-06-01) -
Reduced tolerogenic factor sCD83 in NMOSD and relapsing MOGAD: a potential new therapeutic pathway
by: Ariel Rechtman, et al.
Published: (2025-07-01) -
Investigation of the association of serum GFAP and NfL with brain and upper cervical MRI volumes in AQP4-IgG-positive NMOSD and MOGAD
by: Patrick Schindler, et al.
Published: (2025-07-01) -
MOG35 − 55-induced EAE model of optic nerve inflammation compared to MS, MOGAD and NMOSD related subtypes of human optic neuritis
by: Erin N. Capper, et al.
Published: (2025-04-01)